Together for Short Lives
Call the Helpline 0808 8088 100

Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration

Journal title
Pediatrics
Publication year
2001
Author(s)
Smith, W. E.; Millington, D. S.; Koeberl, D. D.; Lesser, P. S.
Pages
1184-7
Volume
107
Number
5

We report a child initially diagnosed with promethazine-induced dystonia despite a lack of response to diphenhydramine therapy. On further evaluation, the child was diagnosed with glutaric acidemia, type I (GA-I), an autosomal recessive inborn error of metabolism caused by the deficiency of glutaryl-CoA dehydrogenase. The characteristic clinical feature of GA-I is an acute encephalopathic and neurologic crisis typically occurring during a catabolic state. Despite slow improvement, many patients do not fully recover from a neurologic crisis, and residual neurologic morbidity can be significant. Although newborn screening using tandem mass spectrometry is expected to enable presymptomatic diagnosis of GA-I, this patient was not detected by newborn screening with tandem mass spectrometry. Therefore, a high suspicion of GA-I must be maintained in the evaluation of childhood dystonia, even when newborn screening results are reportedly normal.

Research abstracts